Autoimmune endocrine diseases like type 1 diabetes mellitus cause significant disability. Research into their complex causes offers hope for targeted treatments beyond hormone replacement therapy.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Autoimmune endocrine diseases represent a significant health burden, encompassing conditions such as type 1 diabetes mellitus, thyroiditis, Graves disease, Addison disease, and polyglandular syndromes.
These disorders consume substantial healthcare resources and lead to considerable patient disability.
Purpose of the Study:
To summarize the current understanding of autoimmune endocrine diseases.
To highlight recent advancements in immunologic physiology aiding disease analysis.
To discuss current and future therapeutic strategies.
Main Methods:
Review of recent investigations applying immunologic physiology to study autoimmune diseases.
Analysis of genetic predispositions and varied pathogenesis.
Evaluation of current treatment modalities and future therapeutic prospects.
Main Results:
Autoimmune endocrine diseases exhibit complex pathogenesis and intricate genetic underpinnings.
New knowledge in immunologic physiology has been crucial in dissecting these disorders.
Current treatments primarily involve hormone replacement for damaged endocrine organs.
Conclusions:
Understanding the pathogenesis of autoimmune endocrine diseases is key to developing specific therapies.
Future research holds promise for treatments that target the underlying pathology, moving beyond symptomatic management.